ChineseInvestors.com, Inc. (CIIX)

Our latest clients all have the potential to grow significantly in the near and long-term future

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Mon Sep 11, 2017 4:29 pm

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Retains Biopsy, LLC to Provide Leadership in Growth and E-Commerce

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its retention of Biopsy, LLC, managed by bestselling author Chris J. Snook, to provide leadership in growth and e-commerce. Effective September 1, 2017, Biopsy, LLC will serve as the architect of the digital infrastructure and go-to-market strategy for ChineseInvestors.com, Inc. and its subsidiaries, reporting directly to the companies’ management teams. “ChineseInvestors.com, Inc. is fortunate to be able to contract with Biopsy, LLC as Chris’ unique skill and experience will enhance the Company’s ability to effectively emerge as a leader in the CBD Biotechnology Industry, while also strengthening and expanding the market reach and value of the Company’s core financial media business,” Warren Wang, CEO and founder of CIIX, stated in the news release. “Online purchases by Chinese consumers now exceed that of US consumers and global online sales are expected to grow 20% annually. ChineseInvestors.com, Inc. is committed to building the necessary platforms to capitalize on this growth trend and to emerge as a market leader.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 613
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Tue Sep 12, 2017 4:22 pm

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Records 76% YOY Increase in Revenues for FY2017

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its financial results for the fiscal year ended May 31, 2017. Among the highlights, the company recorded a 76 percent increase in total operating revenues as compared to 2016. CIIX noted that both its investor relations business and its subscription business posted strong growth during the 12-month period, with revenues increasing by 130 percent and 57 percent, respectively. The company also provided an update on its outlook for fiscal year 2018. “Although the business of our Consumer Division is still in the early stages, the recently launched ‘OptHemp’ product line is gaining popularity among Chinese consumers in the US, and the Company’s first hemp-infused skin care product line will launch in China in the coming months,” Warren Wang, founder and CEO of CIIX, stated in the news release. “We believe that through the efforts of our business strategists … we will generate substantial revenues in FY 2018 via sales of our hemp-based products in the United States and China. Our overall goal in 2018 is for the Company is to achieve annual revenue growth of more than 100%, while cutting costs and achieving profitability.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 613
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Thu Sep 14, 2017 5:03 pm

Innovative Cannabis Players Offer Promising Entry into Explosive Market

NetworkNewsWire Editorial Coverage: It is no secret that the legal marijuana market is exploding in North America. Analysts have predicted the cannabis market in the United States could reach $24.1 billion by 2025, and recent polls indicate 61 percent of Americans now believe marijuana use should be federally legalized1. Measures are currently being taken in Canada to legalize recreational marijuana by 2018. On a global scale, the worldwide cannabis market has been projected to reach up to $55.8 billion USD by 20252. A wide variety of players have been scrambling to stake a claim in this booming market, whether through directly handling the marijuana plant or by serving those who do. Unique standouts in this burgeoning market include ChineseInvestors.com, Inc. (CIIX) (CIIX Profile), CV Sciences, Inc. (CVSI), Terra Tech Corp. (TRTC), Medical Marijuana, Inc. (MJNA) and Hemp, Inc. (HEMP).

ChineseInvestors.com, Inc. (CIIX) is tapping into a profitable niche market as it serves Chinese-speaking consumers throughout the world and aims to become the largest publicly traded Chinese medical marijuana company.

CIIX is focused on the research, development and distribution of legalized cannabidiol (CBD) to the global Chinese-speaking community. Already one of the fastest growing segments in the U.S. hemp and legal marijuana industry, application of CBD is also gaining traction in China. CIIX operates an online store in the free trade zone of Shanghai, China, where CBD sales are legal, though marijuana use is not. CIIX also recently established, through its wholly owned subsidiary ChineseHempOil.com, Inc., a club-style Hemp Education Center in the company’s home market of San Gabriel, California, to educate interested parties regarding the potential health benefits of non-industrial hemp and hemp-derived CBD (http://nnw.fm/oV4Ga).

CIIX recently engaged Arizona-based Launch Haus LLC, a holding company that specializes in digital direct-to-consumer marketing and product branding, to aid in growing the company’s worldwide sales of hemp-based CBD products (http://nnw.fm/RVz21). In June 2017, the company further incorporated CBD Biotechnology Inc. in British Columbia, Canada, as part of its efforts to enter the medical marijuana market there. Medical marijuana has been federally legal in Canada since 2001, and the Canadian government is now making strides toward the national legalization of recreational marijuana.

“The incorporation of CBD Biotechnology Inc. is a promising step forward toward CIIX’s goals to enter the medical marijuana industry. Through its expansion into Canada, CIIX aims to generate significant revenues through sales of CBD-based health products, while helping the nearly one million Chinese in Canada to improve their overall health,” Warren Wang, founder and CEO of CIIX, stated in a news release (http://nnw.fm/9y0Dc).

In December 2016, CIIX entered into a wholesale agreement with a well-known CBD health brand and formally launched a website for its subsidiary, ChineseCBDoil.com, which went live in January 2017. This launch marked the introduction of the world’s first Chinese language online store for CBD health products. At that same time, CIIX debuted the first Chinese language Yelp-style social media app where users can discuss and review cannabis services and products, as well as find locations of dispensaries.

The company has built a widespread user base of more than 100,000 individuals, and it continues its focus on investing in both the R&D and distribution of CBD products. Corporate objectives include plans to further its study into the effectiveness of CBD for medicinal purposes in an effort to become the first company in China to employ CBD oil as a means of mitigating the suffering of epilepsy and Alzheimer’s patients. The application period for such new drugs in China is only two to four years—significantly shorter than the time it often takes companies to fulfill regulatory requirements in the United States.

As CIIX continues to penetrate new markets, others are taking notice. Consilium Global Research recently projected a CAGR of almost 100 percent for CIIX through 2026 (http://nnw.fm/e5EiK), predicting revenues of up to $14.8 million.

Another standout cannabis player is CV Sciences, Inc. (CVSI), which operates two distinct divisions: pharmaceuticals and consumer products. The company’s pharmaceuticals division is focused on the development and commercialization of novel therapeutics that utilize synthetic CBD. Its consumer products division manufactures, markets and sells plant-based CBD products to various market sectors, distributing these products nationally through the Internet as well as through health food stores and health care provider offices. The company’s divisions are backed by a medical and scientific advisory board, as well as state-of-the-art production facilities, and its consumer products are supported by formal safety reviews, increasing case reports and recommendations from physicians. CV Sciences is pursuing FDA approval for drugs with particular indications, featuring CBD as the active pharmaceutical ingredient, and the company has achieved promising preclinical results. CV Sciences’ initial drug candidate is CVSI-007, a chewing gum that contains nicotine and synthetic CBD to aid individuals in quitting tobacco use and escaping addiction.

Vertically integrated, cannabis-focused agricultural company Terra Tech Corp. (TRTC) is another interesting marijuana play, operating through various subsidiaries including Blüm, IVXX Inc., Edible Garden and MediFarm LLC. Three of these subsidiaries are cannabis-focused. Blüm operates retail and medical cannabis facilities that deliver high-quality medical marijuana products to patients seeking alternative treatments for chronic medical conditions, as well as premium cannabis for Nevada’s adult-use market. IVXX, Inc. produces cannabis-extracted products for regulated medical marijuana dispensaries throughout California and adult-use and medical cannabis dispensaries in Nevada. Under the IVXX brand, Terra Tech recently filed a patent with the U.S. Patent and Trademark Office for cannabis-infused rolling papers, which are anticipated to be released in 2018. The company’s MediFarm LLC subsidiaries are focused on medical and adult-use cultivation and permitting businesses in Nevada.

Medical Marijuana, Inc. (MJNA) stood out as the first company to offer hemp-based CBD products in the United States. The company accomplished this by offering cannabis-derived products that exploit the health properties of non-psychoactive cannabinoids, like CBD, which are legal in the U.S. The company uses cannabis varieties (hemp) that are grown outside the U.S. and either have very low tetrahydrocannabinol levels or no THC at all. Carefully cultivated CBD hemp oil and hemp oil products, offering a full range of phytocannabinoids and high CBD content, are created and then imported into the U.S. In addition to being the first publicly traded cannabis company in the U.S., MJNA has stood out as the first company to bring legal medical cannabis products to Mexico, Brazil, Puerto Rico and Paraguay; the first company to offer government-subsidized botanical cannabis-based products; the first company to deliver prescription CBD products to treat epilepsy, Alzheimer’s, Parkinson’s, chronic pain and migraine; the first company to deliver cannabis brands across U.S. state lines and international borders; and more.

Hemp, Inc. (HEMP) is an industrial hemp-focused company that aims to become a leader in the industrial hemp market through a portfolio of synergistic businesses formed through purchase, acquisition or joint venture with companies across various hemp industry sectors. Hemp, Inc.’s mission is to offer green solutions through its hemp products, which are eco-friendly and can often be used in place of petroleum-based products. The American hemp fiber industry has been estimated at over $500 million, and a hemp crop is known to be more economical and ecological than cotton or trees, reducing water, energy and pesticide use. Hemp, Inc.’s products include DrillWall lost circulation material for oil field drilling application and Spill-Be-Gone and SpillSuck for large- and small-scale oil spill cleanup. The company is also developing SpillMaster for offshore oil spill cleanup.

For investors seeking play in the cannabis market, the mentioned companies offer intriguing and varied opportunities. As this burgeoning market continues its forward drive, these companies may provide promising opportunities to climb aboard.

Editorial Sources:
1) CBS News: http://nnw.fm/5Qh2x
2) Grand View Research: http://nnw.fm/Gf3dQ

For more on CIIX please visit: ChineseInvestors.com (CIIX) or www.ChineseInvestors.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 613
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Fri Sep 15, 2017 3:39 pm

ChineseInvestors.com, Inc. (CIIX) Sets Goal of Greater than 100% Gain in FY2018 Revenues

- In FY2017, the company’s investor relations business grew 130%, and its subscriptions business rose by 57%
- Warren Wang, founder and chief executive officer of CIIX, sets goal of greater than 100% gain in sales in FY2018 and cost-cutting to achieve profitability
- Company excited about its expansion of auxiliary services into the digital currency industry; Wang says that market will offer long-term opportunities

ChineseInvestors.com, Inc. (OTCQB: CIIX) recorded a skyrocketing 76% year-over-year operating revenues increase for its fiscal year ended May 31, 2017. The company’s two divisions exhibited double-digit and triple-digit growth in FY2017. The investor relations business grew 130%, while the subscriptions business rose 57% during the 2017 fiscal year, the company reported (http://nnw.fm/UF4Gn). Total sales grew to $1,667,977 in FY2017 compared to $948,385 the prior year.

Warren Wang, founder and chief executive officer of CIIX, says the company’s goal is more than a 100% jump in FY2018 sales, while cutting costs and achieving profitability.

The primary reason for the increase in sales for the two divisions was a decision by management to be more discerning in deciding which companies would receive its investor relations services. Also, the firm placed itself on a more cash compensation basis — resulting in more sales — rather than taking equity compensation.

CIIX has a goal of becoming the primary Chinese medical cannabis publicly traded company. It is focused on the R&D and distribution of legalized, hemp-based cannabidiol (CBD) to the global Chinese-speaking community. It maintains an online store in the free trade zone of Shanghai, China, and plans on opening a brick-and-mortar outlet in San Gabriel, California.

Before the end of 2017, CIIX plans to launch a cryptocurrency education and trading subscription service and the first Chinese daily video news broadcast from the NYSE covering digital currency and blockchain technology. It has also established CBD Biotechnology Co., Ltd., as a wholly-owned subsidiary in Shanghai, China. It launched OptHemp, its first hemp oil product line. In the coming months, the company said, it will unveil in China its first hemp-infused skin care product line.

“I am very pleased about the Company’s significant increase in revenue in the fiscal year ended May 31, 2017,” Warren Wang, founder and chief executive officer of CIIX, stated in a news release. “Although the blueprint of our Company’s business strategy has expanded through its entrance into the Hemp Industry, our core subscription and investors relations services remain strong with significant growth rates. I am thankful for the investors who have supported our ongoing development plans and look forward to a prosperous year ahead.”

For its non-industrial hemp-based products, the company has engaged Scottsdale, Arizona-based Launch Haus LLC to help it in its direct response marketing, digital, e-commerce and direct sales channels.

In addition, the company has thus far realized $2 million through August 29, 2017, from its private placement of some 10 million shares of its Series D-2017 convertible preferred stock, priced at $1 per share.

For more information, visit the company’s website at www.ChineseInvestors.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 613
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Mon Sep 18, 2017 4:09 pm

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Subsidiary Completes China FDA Filing; Moves toward Launch of Hemp-Infused Skin Care Line

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX), through wholly-owned subsidiary CBD Biotechnology Co. Ltd., this morning announced that it has completed the record filing process with the China Food & Drug Administration (“CFDA”) for its first line of non-industrial hemp-infused skin care products. Following this milestone, the company expects to launch its ‘CBD Magic Hemp Series’ skin care line in the next couple of months, effectively positioning CBD Biotechnology as a leader in what the company has called “an untapped segment of China’s skin care industry.” “I am very pleased to announce the upcoming launch of CBD Biotechnology’s non-industrial hemp-infused skin care line, CBD Magic Hemp Series,” Summer Yun, CEO of CBD Biotechnology, stated in the news release. “We have not only completed the filing process with CFDA, but we have also contracted with a large processing factory in Shanghai, China, with over 14-years of experience in cosmetics production.” Upon launch, the initial CBD Magic Hemp Series product line is expected to include a brightening and refreshing moisturizer, a perfecting shield primer and a peptide collagen solution.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 613
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Wed Sep 20, 2017 3:54 pm

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Director Featured in SmallCapVoice Interview

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that its director of investor relations, Alan Klitenic, was featured in a recent interview with SmallCapVoice.com. In the interview, which can be heard at http://nnw.fm/flQB8, Klitenic discusses CIIX’s recent news, including updates related to the digital currency industry, the company’s plans to launch a Chinese daily video news broadcast from the NYSE floor, CIIX’s recent financial performance and its completion of the record filing process with the Chinese FDA related to its soon-to-be-launched hemp infused skin care line. “I want to emphatically state that CIIX is ready to make sales in China,” Klitenic stated during the interview. “We have successfully passed through the regulatory body, the China FDA. We have manufactured this product: CBD Infused skin care products line with a design patent. This is a real milestone for us at ChineseInvestors.com. We are going to spend money and promote our CBD Hemp Oil and CBD infused skin care products in China going forward from now and through 2018.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 613
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Thu Sep 21, 2017 6:18 pm

Cannabinoid Consumer Market Booming as CBD Enjoys Growth in Public Sentiment

NetworkNewsWire Editorial Coverage: Medical cannabis sales are set to impress even the most timid investor, with projected sales of nearly $5 billion in 2017, or about 67% of the $7.2 billion legal cannabis market. Hemp-derived cannabidiol (CBD) product sales are also expected to be a billion-dollar business within three years, growing at a projected 55% compound annual growth rate from 2016’s $170 million in revenue, according to an article in Forbes(1). As the cannabis industry continues to flourish, many publicly traded companies are finding ample opportunities to thrive. Standout companies determined to grow with the industry include ChineseInvestors.com (CIIX) (CIIX Profile), CV Sciences, Inc. (CVSI), Terra Tech Corp. (TRTC), Medical Marijuana, Inc. (MJNA) and Hemp, Inc. (HEMP)

It’s worthwhile to note that significant changes in the acceptance of medical and recreational marijuana also includes the alternative forms of CBD-infused and hemp-derived products, which most people now understand do not contain THC, the psychoactive compound found in marijuana. A massive amount of research into the health benefits of CBD and its effect on mental health disorders is also underway in the scientific community.

Branching out into the unique adaptations of the hemp oil business made perfect business sense for ChineseInvestors.com (CIIX) (www.ChineseInvestors.com), a leading financial information website for Chinese-speaking consumers and investors. CIIX has already established two wholly-owned subsidiaries based in China and the United States. CBD Biotechnology Co., Ltd., located in the free trade zone of Shanghai, China, has plans to deliver a hemp-infused skin care line in China before the end of 2017, while ChineseHempOil.com, Inc., located in the U.S., has launched its first hemp oil product line, “OptHemp.” Customers of ChineseHempOil.com can also purchase the company’s hemp-based products, foods and beverages using bitcoin (http://nnw.fm/w3pbB). The company’s annual financial results, released Tuesday, show a 76% YoY increase in revenues along with an array of new business ventures successfully being introduced to investors.

Among its offerings is the first marijuana social media mobile app designed for Chinese-speaking customers worldwide with a beta version slated for release in November. Its direct-to-consumer e-commerce business is projecting a compound annual growth rate (CAGR) of nearly 100% through FY2020, with revenues reaching $14.8 million. CIIX is positioning itself as a global leader with a goal of becoming the largest Chinese publicly traded company in the legalized CBD market targeting the world’s Chinese-speaking communities (http://nnw.fm/yA6bN).

Another company seeking to make a difference in the rapidly expanding CBD marketplace of cannabis-related products is CV Sciences, Inc. (CVSI), a preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil. The company plans to exhibit its PlusCBD Oil ™ product brand at the Natural Products Expo East September 14-16 in Baltimore, Maryland. The trade show brings together over 28,000 industry professionals and 1,400 exhibitors. CV Sciences’ product brand is sold at approximately 1,300 health food stores and continues to grow its shelf presence in various retail outlets across the county. In a news release, company spokesman Stuart Tomc said, “It’s evident that hemp-derived CBD products are doing better and growing faster than almost every other category in the supplement industry (http://nnw.fm/H2kId).”

Terra Tech Corp. (TRTC), a vertically integrated, cannabis-focused agriculture company, is also expanding its retail operations. Terra Tech Corp. operates multiple dispensaries as well as cultivation and extraction facilities in California and Nevada. Terra Tech CEO Derek Peterson said the company’s recent acquisition of Tech Center Drive Management LLC, which operates The Reserve OC medical cannabis dispensary in Santa Ana, California, represents another milestone.

“California has emerged as one of the United States’ leading legal cannabis markets, with adult-use planned to come online in 2018,” Peterson said in a news release. “Terra Tech will continue to identify opportunities to expand both its retail and cultivation capabilities in these core markets to drive forward our growth strategy and build value for shareholders (http://cnw.fm/h42vC).”

Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced that August 2017 was the company’s largest revenue month in its history. Its wholly owned subsidiaries Kannaway® and HempMeds® Mexico also experienced the best revenue month in their respective histories, Kannaway CEO Blake Schroeder said in a news release (http://cnw.fm/Evae6), noting the company’s plans to launch a series of new products in Q4 2017 as it gears up for its regional convention in Denver, Colorado, this fall. Expansion plans for entering the European market are expected to contribute to the company’s explosive growth, Schroeder added.

Making significant progress in its bid to be known as the world’s number one industrial hemp producer and exporter, HEMP, Inc. (HEMP) has appointed Dr. Robert Ian Bruck, director and founder of the North Carolina State University Environmental Technology Program, as Dean of Hemp, Inc.’s Hemp University. Bruck, who holds two doctorates and years of experience in the fields of plant pathology and ecology, will be responsible for the management and development of curriculum at The Hemp University. Educating not only the public but public policy makers about the business and scientific aspects of industrial hemp – from how to grow it to the many complexities of CBD – is a critical element of moving the cannabis industry forward., according to a company news release (http://cnw.fm/p1hbY).

While the demand for hemp-based cannabidiol has skyrocketed, so have the number of companies jumping into the market, Marijuana Business Daily reports (http://nnw.fm/7ENhH). There are now hundreds, if not thousands of hemp CBD companies flooding the market looking to take advantage of the profits to be made in the global cannabis industry. For companies like ChineseInvestors.com, which has been in business since 1999, capitalizing on the convergence of CBD and the nutrition and health products market in mainland China was a no-brainer.

In a news release (http://nnw.fm/OpHR2), Keevin Gillespie, newly appointed acting president of the company’s ChineseHempOil.com subsidiary, expressed his enthusiasm for the company’s future.

“As the many potential health benefits of hemp continue to be revealed through scientific research and development, I believe the Chinese community will embrace this rediscovered ancient remedy,” Gillespie stated. “I look forward to creating brand awareness and exposure for the Company’s ‘OptHemp’ product line, developing the Company’s network marketing division and generating significant new revenue streams for the Company in the coming year.”

Editorial Sources:
1) Forbes http://nnw.fm/rv2xH

For more on CIIX please visit: ChineseInvestors.com (CIIX) or www.ChineseInvestors.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 613
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: ChineseInvestors.com, Inc. (CIIX)

Postby QualityStocks » Fri Sep 22, 2017 4:29 pm

For ChineseInvestors.com, Inc. (CIIX) Beauty is more than Just Skin Deep

- Entering largely untapped Chinese CBD skin care market
- Health benefits widely recognized
- Vibrant online marketing campaigns underway

Chinese women, it will be no surprise to learn, are as beauty conscious as their sisters in other countries. For centuries, they have employed a variety of cosmetic embellishments to enhance social status and, perhaps, catch someone’s eye. Lip coloring has been in vogue for at least 1,000 years, and, at some point, the application of powdered rice to lighten skin tone became fashionable. But beauty is more than skin deep, which is perhaps why ChineseInvestors.com, Inc. (OTCQB: CIIX) is launching a line of hemp-infused skin care products in China. The cannabinoid content of the line makes these products more than just cosmetics. The health virtues of cannabinoids are now widely accepted.

It’s not always that you’re known by the company you keep. Cannabidiol (CBD), the main active ingredient in CIIX’s new product line up, is, like THC, derived from cannabis sativa, but unlike its notorious associate, it is not psychotropic. Increasingly, it is being recognized to have therapeutic potential. Indeed, at a United States Senate Caucus, pre-clinical research (including both cell culture and animal models) into CBD was said to have shown ‘a range of effects that may be therapeutically useful, including anti-seizure, antioxidant, neuroprotective, anti-inflammatory, analgesic, anti-tumor, anti-psychotic, and anti-anxiety properties’ (http://nnw.fm/L4W6i). There are already products, like Sativex, that contain CBD, however, there are few directed to skincare, either in the West or in China. As such, this offers CIIX a lucrative opportunity to be a first mover in this space (http://nnw.fm/XV2Bk).

It’s an opportunity the company has embraced vigorously. CIIX recently announced that that its wholly owned foreign enterprise, CBD Biotechnology Co. Ltd., had completed the record filing process with the China Food & Drug Administration (CFDA) for its first line of non-industrial hemp-infused skin care products (http://nnw.fm/Jml1B). CIIX expects to launch the ‘CBD Magic Hemp Series’ skin care line before the end of the year. The initial ‘CBD Magic Hemp Series’ launch will include:

- The CBD BIOTECH Brightening and Refreshing Moisturizer – intended to balance the skin’s moisture while forming a protective, moisturizing layer
- The CBD BIOTECH Perfecting Shield Primer – intended to even skin tone while covering fine lines and minimizing the look of pores; and
- The CBD BIOTECH Peptide Collagen Solution – intended to moisturize and firm the skin while smoothing fine lines and reducing signs of aging.

CIIX targets mainly Chinese-speaking consumers and operates an online store in the free trade zone of Shanghai, China. The company also recently established, through its wholly owned subsidiary ChineseHempOil.com, Inc., a club-style Hemp Education Center in San Gabriel, California, where it is based, to educate interested parties regarding the potential health benefits of non-industrial hemp and hemp-derived CBD. CIIX also engaged Arizona-based Launch Haus LLC, a specialist in digital direct-to-consumer marketing and product branding, to assist in growing the company’s worldwide sales of hemp-based CBD products.

Moreover in June 2017, CIIX incorporated CBD Biotechnology Inc. in British Columbia, Canada, as part of its efforts to enter the medical marijuana market there. CIIX also plans to launch a Chinese language Yelp-style mobile app for locating dispensaries and discussing cannabis products in the US.

For more information, visit the company’s website at www.ChineseInvestors.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 613
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Previous

Return to QualityStocks Featured Companies

Who is online

Users browsing this forum: No registered users and 1 guest

cron